Novo Holdings resumed normal investment allocations after a pause earlier this year, citing improved U.S. market attractiveness despite higher-for-longer interest rates.
FirstSquawk08/13, 01:15 AM
- $109 BLN
Figures as quoted by FirstSquawk
Related assets
Coming up for NVO
Explore next
Latest NVO news
MarketWatch08/27, 03:37 PM
Deutsche Bank downgraded Novo Nordisk to sell after the stock fell 70% from its peak.
Jin1008/27, 10:33 AM
Novo Nordisk has applied for approval of an oral formulation of Wegovy for weight management.
Finnhub08/19, 05:10 PM